Literature DB >> 30064704

Radiomics in Nuclear Medicine Applied to Radiation Therapy: Methods, Pitfalls, and Challenges.

Sylvain Reuzé1, Antoine Schernberg2, Fanny Orlhac3, Roger Sun4, Cyrus Chargari5, Laurent Dercle6, Eric Deutsch4, Irène Buvat3, Charlotte Robert7.   

Abstract

Radiomics is a recent area of research in precision medicine and is based on the extraction of a large variety of features from medical images. In the field of radiation oncology, comprehensive image analysis is crucial to personalization of treatments. A better characterization of local heterogeneity and the shape of the tumor, depicting individual cancer aggressiveness, could guide dose planning and suggest volumes in which a higher dose is needed for better tumor control. In addition, noninvasive imaging features that could predict treatment outcome from baseline scans could help the radiation oncologist to determine the best treatment strategies and to stratify patients as at low risk or high risk of recurrence. Nuclear medicine molecular imaging reflects information regarding biological processes in the tumor thanks to a wide range of radiotracers. Many studies involving 18F-fluorodeoxyglucose positron emission tomography suggest an added value of radiomics compared with the use of conventional PET metrics such as standardized uptake value for both tumor diagnosis and prediction of recurrence or treatment outcome. However, these promising results should not hide technical difficulties that still currently prevent the approach from being widely studied or clinically used. These difficulties mostly pertain to the variability of the imaging features as a function of the acquisition device and protocol, the robustness of the models with respect to that variability, and the interpretation of the radiomic models. Addressing the impact of the variability in acquisition and reconstruction protocols is needed, as is harmonizing the radiomic feature calculation methods, to ensure the reproducibility of studies in a multicenter context and their implementation in a clinical workflow. In this review, we explain the potential impact of positron emission tomography radiomics for radiation therapy and underline the various aspects that need to be carefully addressed to make the most of this promising approach.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30064704     DOI: 10.1016/j.ijrobp.2018.05.022

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  30 in total

1.  Radiomics in nuclear medicine: robustness, reproducibility, standardization, and how to avoid data analysis traps and replication crisis.

Authors:  Alex Zwanenburg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-25       Impact factor: 9.236

2.  AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics.

Authors:  Isabella Castiglioni; Francesca Gallivanone; Paolo Soda; Michele Avanzo; Joseph Stancanello; Marco Aiello; Matteo Interlenghi; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-11       Impact factor: 9.236

3.  Clinical perspectives for the use of total body PET/CT.

Authors:  Ronan Abgral; David Bourhis; Pierre-Yves Salaun
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-06       Impact factor: 9.236

Review 4.  NCTN Assessment on Current Applications of Radiomics in Oncology.

Authors:  Ke Nie; Hania Al-Hallaq; X Allen Li; Stanley H Benedict; Jason W Sohn; Jean M Moran; Yong Fan; Mi Huang; Michael V Knopp; Jeff M Michalski; James Monroe; Ceferino Obcemea; Christina I Tsien; Timothy Solberg; Jackie Wu; Ping Xia; Ying Xiao; Issam El Naqa
Journal:  Int J Radiat Oncol Biol Phys       Date:  2019-01-31       Impact factor: 7.038

5.  Prognostic value of 18F-FDG PET/CT with texture analysis in patients with rectal cancer treated by surgery.

Authors:  Masatoshi Hotta; Ryogo Minamimoto; Yoshimasa Gohda; Kenta Miwa; Kensuke Otani; Tomomichi Kiyomatsu; Hideaki Yano
Journal:  Ann Nucl Med       Date:  2021-05-04       Impact factor: 2.668

6.  Artificial intelligence in medical imaging: A radiomic guide to precision phenotyping of cardiovascular disease.

Authors:  Evangelos K Oikonomou; Musib Siddique; Charalambos Antoniades
Journal:  Cardiovasc Res       Date:  2020-11-01       Impact factor: 10.787

7.  Multi-center evaluation of artificial intelligent imaging and clinical models for predicting neoadjuvant chemotherapy response in breast cancer.

Authors:  Tan Hong Qi; Ong Hiok Hian; Arjunan Muthu Kumaran; Tira J Tan; Tan Ryan Ying Cong; Ghislaine Lee Su-Xin; Elaine Hsuen Lim; Raymond Ng; Ming Chert Richard Yeo; Faye Lynette Lim Wei Tching; Zhang Zewen; Christina Yang Shi Hui; Wong Ru Xin; Su Kai Gideon Ooi; Lester Chee Hao Leong; Su Ming Tan; Madhukumar Preetha; Yirong Sim; Veronique Kiak Mien Tan; Joe Yeong; Wong Fuh Yong; Yiyu Cai; Wen Long Nei
Journal:  Breast Cancer Res Treat       Date:  2022-03-09       Impact factor: 4.872

8.  Quantitative assessment of acquisition imaging parameters on MRI radiomics features: a prospective anthropomorphic phantom study using a 3D-T2W-TSE sequence for MR-guided-radiotherapy.

Authors:  Jing Yuan; Cindy Xue; Gladys Lo; Oi Lei Wong; Yihang Zhou; Siu Ki Yu; Kin Yin Cheung
Journal:  Quant Imaging Med Surg       Date:  2021-05

Review 9.  Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy.

Authors:  Laetitia Vercellino; Dorine de Jong; Roberta di Blasi; Salim Kanoun; Ran Reshef; Lawrence H Schwartz; Laurent Dercle
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

10.  Experimental phantom evaluation to identify robust positron emission tomography (PET) radiomic features.

Authors:  Montserrat Carles; Tobias Fechter; Luis Martí-Bonmatí; Dimos Baltas; Michael Mix
Journal:  EJNMMI Phys       Date:  2021-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.